RMC No. 58-2022: Updates to VAT-Exempt Medicines List Including Hypertension and COVID-19 Treatments
RMC No. 58-2022 publishes FDA corrections to VAT-exempt medicines, affecting hypertension and COVID-19 treatments. Businesses must update records and invoices to remain compliant. Businesses and healthcare providers must immediately note changes to the VAT-exempt status of certain medicines. RMC No. 58-2022 publishes the FDA’s updates correcting names of specific medicines used for hypertension and COVID-19 […]